Navigation Links
PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
Date:12/6/2007

a better understanding of real-

world treatment patterns and clinical outcomes in patients with cancer

receiving chemotherapy and ESA therapy.

Data on PROCRIT in Managed Care Settings

-- Abstract: Drug Utilization Patterns and Cost Considerations for

Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a

Managed Care Setting

Alyson Mandel, Ph.D., Medical Practice Data Corporation, Claverack, NY

Publication Number 5157

A retrospective, observational analysis of ESA utilization in more than

4,100 chemotherapy patients using adjudicated medical claims between

2004 and 2006 from seven health plans was conducted to understand

current utilization patterns. The study examined real-world dosing and

drug costs for ESAs (Epoetin alfa and darbepoetin alfa) in cancer

patients receiving chemotherapy.

-- Abstract: Medical Visit Patterns in Cancer Chemotherapy Patients

Receiving Erythropoiesis Stimulating Agents in a Managed Care Setting

Alyson Mandel, Ph.D., Medical Practice Data Corporation, Claverack, NY

Publication Number 5156

A retrospective analysis of medical claims between January 2004 and

December 2005 using the Integrated Health Care Information Systems

national database and representing more than 35 health plans was

conducted to describe visit patterns and identify the proportion of

medical visits made exclusively for ESA treatment in cancer

chemotherapy patients.

Observational Data from the DOSE Registry

-- Abstract: Hemoglobin Levels Prior To Blood Transfusions In Oncology

Patients Receiving Chemotherapy and Erythropoiesis-Stimulating Agents

(ESAs): Observational Data from the DOSE Registry

Kay Larholt, Sc.D., Abt Associates, Lexington, MA

Publication Number 4019

A retrospective an
'/>"/>

SOURCE Ortho Biotech
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... , Aug. 1, 2014 MGC Diagnostics ... company, announced today that it has completed its ... of cardiorespiratory diagnostic products based in Sorinnes, ... served the European cardiorespiratory diagnostics market since 1977. ... of approximately €4.7 million ($6.3 million) and incurred ...
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... SAN DIEGO , July 31, 2014  Sorrento Therapeutics, ... death of Mr. Amar Singh , Chief Business Officer ... of apparent natural causes on July 30. "Sorrento ... dear friend and colleague. Our immediate thoughts go to Amar,s ... President and Chief Executive Officer. Mr. Singh ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2
... 2, 2012  Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... the month of February, its Food and Drug Administration ... NAI (No Action Indicated) for the inspection. ... perform unannounced inspections for medical device manufacturers and the ...
... N.J., March 2, 2012 Watson Pharmaceuticals, Inc. ... Watson has launched an authorized generic version of ... part of an agreement with Abbott Laboratories. Watson ... indicated for use in the prevention of endometrial ...
Cached Medicine Technology:Solos Endoscopy, Inc. Successfully Completes Level I FDA Inspection 2Watson Launches Generic PROMETRIUM(R) 2
(Date:8/1/2014)... 01, 2014 On Monday, June 30th, ... User Symposium in San Francisco, CA. Now in its ... JW Marriott Union Square hotel. , “We are excited ... to speed with ACA compliance issues,” Quirk Healthcare Foundation ... symposium provides attendees guidance with NextGen implementation and use, ...
(Date:8/1/2014)... Alan Mozes HealthDay Reporter ... country, barbershops serve as a time-honored destination for a good ... whether barbershops might also be the spot to tackle an ... In a novel partnership, the U.S. Centers for Disease ... Health (MSDH), enlisted the help of barbershop staff to both ...
(Date:8/1/2014)... The North America Endpoint Security Market report defines and ... with analysis and forecast of revenue. This market is ... to $4.77 billion by 2019, at a CAGR of ... TOC of the North America Endpoint Security Market report ... It also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... 1, 2014 The Cardiovascular Research Foundation (CRF) ... investigations that will be presented at next month,s ... the world,s premier educational meeting specializing in interventional ... 17, 2014 at the Walter E. Washington Convention ... presented at TCT often direct the course of ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... The company develops biomarkers. Its products include CytoSure ... ISCA +SNP Array, CytoSure ISCA UPD array, CytoSure ... v2 array. OGT offers services, such as targeted ... RNA-Seq service, miRNA analysis, gene expression analysis, cytosure ...
Breaking Medicine News(10 mins):Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 2Health News:Oxford Gene Technology Market Size, Share, Analysis, Trends and Forecasts 2014 3
... SALAAM, Tanzania, April 25 Today is a,great day for ... and a day to,celebrate. We celebrate because of the possibilities ... today by the United,Nations Secretary General His Excellency Ban Ki-Moon, ... initiative is implemented to the,letter, millions of lives will be ...
... Inc. (NYSE:,NTY) (http://www.NBTY.com ), a leading global manufacturer ... web cast the,presentation by Harvey Kamil, President and Chief ... And Restaurant Conference in,New York on Tuesday, April 29, ... cast live on the Company Web,site, http://www.nbty.com ...
... (Nasdaq: THOR ), a world leader in ... restore failing hearts,today announced that it will report ... 2008 on Thursday, May 1., The company ... financial,results and operating activities to all interested parties ...
... and who,s telling the truth , , FRIDAY, April 25 ... window into the soul, but scientists have been reporting ... imperceptible facial expressions -- tell the real story of ... that people have a lot more trouble hiding their ...
... and reduced risk of recurrence during tuberculosis chemotherapy, according ... of The Journal of Infectious Diseases, now available online. ... common before the advent of anti-TB drugs, is no ... low-income countries even though poor nutrition impairs the immune ...
... Inc.,(Nasdaq: SMBL ) will hold its annual meeting ... 2008, at the Teaneck Marriott at Glenpointe, 100,Frank W. ... the close of business on April 2, 2008, are ... come before the meeting., About Smart Balance Inc., ...
Cached Medicine News:Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2Health News:NBTY to Webcast Presentation at Lehman Brothers 11th Annual Retail and Restaurant Conference 2Health News:Thoratec Schedules First Quarter 2008 Conference Call, Webcast 2Health News:Fleeting Facial Expressions Reveal Deep Secrets 2Health News:Fleeting Facial Expressions Reveal Deep Secrets 3Health News:Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence 2
... For Excellent Drainage PLUS Greater Patient ... BLAKE Drains are white, radiopaque silicone drains ... a solid core center. Their other components ... extension tubing and an adapter. The drains ...
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte...
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
Used for common bile duct exploration. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: